Skip to main content
Erschienen in: Pediatric Cardiology 6/2021

23.04.2021 | Original Article

Conduction Properties and Ablation of Adenosine Sensitive Accessory Pathways in Children

verfasst von: Chalese Richardson, Eric S. Silver, Leonardo Liberman

Erschienen in: Pediatric Cardiology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Block in accessory pathway (AP) conduction with adenosine has been previously described. However, conduction characteristics of these APs has not been well defined to date. All patients with APs </ = 21 years old who underwent an EP study from 2014 to 2017 were included in our study. Patients with adenosine sensitive APs were identified (group 1). Demographic and AP conduction characteristics were compared between group 1 and the entire cohort of patients. Local atrioventricular (AV) or ventriculoatrial (VA) time, cycle length and need for isoproterenol were compared to a control group matched by age and AP location (group 2). Student’s t test, Wilcoxon rank sum, χ2 and Fisher’s exact were used for analysis. Fourteen (7%) out of 207 patients had an adenosine sensitive AP. The median age of patients with adenosine sensitive APs was 11.8 (IQR 8.5–13.5) years vs. 14 (IQR 10.6–16.7) for the rest of the cohort (p = 0.04). Three of the 134 patients with preexcitation had adenosine sensitive APs (2%) vs. 11 of the 73 patients with concealed APs (15%) (p = 0.001). The median local AV/VA time at the site of successful ablation was longer in group 1 vs group 2 [78 ms, IQR 62–116 vs. 31 ms, IQR 30–38; p < 0.001]. Antegrade AP effective refractory period and total procedure time were longer in patients with adenosine sensitive APs (p = 0.03 & p = 0.04, respectively). Adenosine sensitive APs which occur in children are more often concealed. These APs have a longer conduction time at the site of successful ablation.
Literatur
1.
Zurück zum Zitat Perrot B, Clozel P, Faivre G (1984) Effect of adenosine triphosphate on the accessory pathways. Eur Heart J 5:382–393PubMedCrossRef Perrot B, Clozel P, Faivre G (1984) Effect of adenosine triphosphate on the accessory pathways. Eur Heart J 5:382–393PubMedCrossRef
2.
Zurück zum Zitat Rinne C, Sharma AD, Klein GJ, Yee R, Szabo T (1988) Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction. Am Heart J 115:1042–1047PubMedCrossRef Rinne C, Sharma AD, Klein GJ, Yee R, Szabo T (1988) Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction. Am Heart J 115:1042–1047PubMedCrossRef
3.
Zurück zum Zitat Keim S, Curtis AB, Belardinelli L, Epstein ML, Staples ED, Lerman BB (1992) Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways. J Am Coll Cardiol 19:1005–1012PubMedCrossRef Keim S, Curtis AB, Belardinelli L, Epstein ML, Staples ED, Lerman BB (1992) Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways. J Am Coll Cardiol 19:1005–1012PubMedCrossRef
4.
Zurück zum Zitat Walker KW, McAnulty JH, Kron J, Silka MJ, Halperin BD (1993) Unmasking accessory pathway conduction with adenosine-induced atrioventricular nodal block after radiofrequency catheter ablation. Chest 104:1614–1616PubMedCrossRef Walker KW, McAnulty JH, Kron J, Silka MJ, Halperin BD (1993) Unmasking accessory pathway conduction with adenosine-induced atrioventricular nodal block after radiofrequency catheter ablation. Chest 104:1614–1616PubMedCrossRef
5.
Zurück zum Zitat Engelstein ED, Wilber D, Wadas M, Stein KM, Lippman N, Lerman BB (1994) Limitations of adenosine in assessing the efficacy of radiofrequency catheter ablation of accessory pathways. Am J Cardiol 73:774–779PubMedCrossRef Engelstein ED, Wilber D, Wadas M, Stein KM, Lippman N, Lerman BB (1994) Limitations of adenosine in assessing the efficacy of radiofrequency catheter ablation of accessory pathways. Am J Cardiol 73:774–779PubMedCrossRef
6.
Zurück zum Zitat Fishberger SB, Saul JP, Triedman JK, Epstein MR, Walsh EP (1995) Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol 5:1278–1281CrossRef Fishberger SB, Saul JP, Triedman JK, Epstein MR, Walsh EP (1995) Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol 5:1278–1281CrossRef
7.
Zurück zum Zitat Lerman BB, Greenberg M, Overholt ED, Swerdlow CD, Smith RT, Sellers TD, DiMarco JP (1987) Differential electrophysiologic properties of decremental retrograde pathways in long RP’ tachycardia. Circulation 76:21–31PubMedCrossRef Lerman BB, Greenberg M, Overholt ED, Swerdlow CD, Smith RT, Sellers TD, DiMarco JP (1987) Differential electrophysiologic properties of decremental retrograde pathways in long RP’ tachycardia. Circulation 76:21–31PubMedCrossRef
8.
Zurück zum Zitat Chen SA, Tai CT, Chiang CE, Lee SH, Wen ZC, Chiou CW, Ueng KC et al (1996) Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway. J Am Coll Cardiol 28:732–737PubMedCrossRef Chen SA, Tai CT, Chiang CE, Lee SH, Wen ZC, Chiou CW, Ueng KC et al (1996) Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway. J Am Coll Cardiol 28:732–737PubMedCrossRef
9.
Zurück zum Zitat Beach C, Follansbee CW, Beerman L, Mazzocco S, Wang L, Arora G (2018) Adenosine-sensitive Wolff-Parkinson-White: longer time across the atrioventricular groove. Pacing Clin Electrophysiol 41:35–41PubMedCrossRef Beach C, Follansbee CW, Beerman L, Mazzocco S, Wang L, Arora G (2018) Adenosine-sensitive Wolff-Parkinson-White: longer time across the atrioventricular groove. Pacing Clin Electrophysiol 41:35–41PubMedCrossRef
10.
Zurück zum Zitat Wackel P, Berman L, Arora G (2013) Wolff-Parkinson-White syndrome and adenosine response in pediatric patients. Pacing Clin Electrophysol 36:491–496CrossRef Wackel P, Berman L, Arora G (2013) Wolff-Parkinson-White syndrome and adenosine response in pediatric patients. Pacing Clin Electrophysol 36:491–496CrossRef
11.
Zurück zum Zitat Vaksmann G, D’hoinne C, Lucet V, Guillaumont S, Lupoglazoff J-M, Chantepie A, Vaksmann G (2006) Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart 92:101–104PubMedCrossRef Vaksmann G, D’hoinne C, Lucet V, Guillaumont S, Lupoglazoff J-M, Chantepie A, Vaksmann G (2006) Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart 92:101–104PubMedCrossRef
12.
Zurück zum Zitat Critelli G, Gallagher JJ, Monda V, Coltori F, Scherillo M, Rossi L (1984) Anatomic and electrophysiologic substrate of the permanent form of junctional reciprocating tachycardia. J Am Coll Cardiol 4:601–610PubMedCrossRef Critelli G, Gallagher JJ, Monda V, Coltori F, Scherillo M, Rossi L (1984) Anatomic and electrophysiologic substrate of the permanent form of junctional reciprocating tachycardia. J Am Coll Cardiol 4:601–610PubMedCrossRef
13.
Zurück zum Zitat Calkins H, Kim YN, Schmaltz S, Sousa J, El-Atassi R, Leon A, Kadish A et al (1992) Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory: atrioventricular connections. Circulation 85:565–573PubMedCrossRef Calkins H, Kim YN, Schmaltz S, Sousa J, El-Atassi R, Leon A, Kadish A et al (1992) Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory: atrioventricular connections. Circulation 85:565–573PubMedCrossRef
14.
Zurück zum Zitat Grimm W, Miller J, Josephson ME (1994) Successful and unsuccessful sites of radiofrequency catheter ablation of accessory atrioventricular connections. Am Heart J 128:77–87PubMedCrossRef Grimm W, Miller J, Josephson ME (1994) Successful and unsuccessful sites of radiofrequency catheter ablation of accessory atrioventricular connections. Am Heart J 128:77–87PubMedCrossRef
15.
Zurück zum Zitat Xie B, Heald SC, Camm AJ, Rowland E, Ward DE (1996) Successful radiofrequency ablation of accessory pathways with the first energy delivery: the anatomic and electrical characteristics. Eur Heart J 17:1072–1079PubMedCrossRef Xie B, Heald SC, Camm AJ, Rowland E, Ward DE (1996) Successful radiofrequency ablation of accessory pathways with the first energy delivery: the anatomic and electrical characteristics. Eur Heart J 17:1072–1079PubMedCrossRef
Metadaten
Titel
Conduction Properties and Ablation of Adenosine Sensitive Accessory Pathways in Children
verfasst von
Chalese Richardson
Eric S. Silver
Leonardo Liberman
Publikationsdatum
23.04.2021
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 6/2021
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-021-02618-w

Weitere Artikel der Ausgabe 6/2021

Pediatric Cardiology 6/2021 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.